Latest Annuities News

Challenger reports a solid first half of FY26 with rising profits, strong annuity sales, and strategic partnerships, underpinning a confident outlook and a $150 million share buy-back plan.

Challenger Limited reported a solid first half of FY26 with a 2% rise in normalised net profit after tax and record annuity sales. The company also announced a $150 million on-market share buy-back, reflecting confidence in its strong capital position.

Pro Medicus has reported its strongest half-year performance yet, with revenue and profits surging alongside a wave of new multi-million dollar contracts and strategic AI investments. The healthcare IT leader is expanding its global footprint and cloud capabilities, setting the stage for sustained growth.

Challenger Limited confirms advanced discussions with Pepper Group to jointly acquire Pepper Money, aiming for strategic access to fixed income assets and accretive earnings.

Range International Limited has reported its strongest quarterly sales and production figures yet in Indonesia, while strategically pivoting towards a pallet rental model to secure more stable revenue streams.

Generation Development Group (ASX, GDG) has reported a robust December quarter, with Funds Under Management surging across its core divisions, driven by strategic partnerships and acquisitions.

Rent.com.au has achieved a significant milestone with RentBond® annuity revenue exceeding $100,000 in a single month, driven by over $1 million in new loans and strategic capital moves that improve profitability.

Comms Group reported robust FY25 results driven by domestic expansion, including the strategic acquisition of TasmaNet, and strong international growth in its Global and Wholesale division.

SRG Global has landed $650 million worth of contracts spanning water, defence, energy, and more across Australia and New Zealand, reinforcing its position as a diversified infrastructure leader.

HiTech Group Australia has reported its strongest financial year yet in FY25, with solid revenue growth and a robust balance sheet, while facing margin pressures in the first half of FY26 due to government spending shifts.

Abacus Group reported a solid FY25 with modest growth in funds from operations and stable distributions, underpinned by strong leasing activity and a diversified commercial portfolio. The Group also highlighted significant progress in sustainability and reaffirmed its FY26 guidance amid improving market conditions.

Cyclopharm Limited reaffirms its ambitious target of 250–300 US Technegas installations by late 2026, driven by FDA approval, CMS reimbursement, and a growing pipeline of healthcare sites. The company reports record half-year revenue growth, signaling strong momentum in the expanding lung imaging market.